A second lung cancer FFPE sample was assayed for a G719A EGFR mutation in combination with a S127F mutation of the tumor suppressor gene TP53 (Fig. 7A, B and Supplementary Fig. 11B). The gene discussed is EGFR; the disease is lung cancer.